X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (171) 171
hematology (166) 166
index medicus (162) 162
transplantation (147) 147
female (146) 146
adult (145) 145
male (144) 144
middle aged (139) 139
stem cells (106) 106
aged (105) 105
adolescent (103) 103
retrospective studies (99) 99
leukemia, myeloid, acute - therapy (81) 81
oncology (77) 77
young adult (75) 75
leukemia (72) 72
treatment outcome (70) 70
transplantation, homologous (68) 68
acute myeloid leukemia (67) 67
bone marrow (61) 61
versus-host-disease (58) 58
acute myeloid-leukemia (57) 57
hematopoietic stem cells (56) 56
survival (55) 55
stem cell transplantation (54) 54
leukemia, myeloid, acute - mortality (53) 53
life sciences (51) 51
stem-cell transplantation (51) 51
disease-free survival (50) 50
hematopoietic stem cell transplantation - methods (50) 50
remission (50) 50
transplantation conditioning - methods (49) 49
analysis (46) 46
multivariate analysis (46) 46
remission induction (46) 46
bone-marrow-transplantation (45) 45
adults (44) 44
prognosis (44) 44
mortality (43) 43
hematopoietic stem cell transplantation (42) 42
recurrence (42) 42
survival analysis (42) 42
myeloid leukemia (41) 41
research (41) 41
unrelated donors (41) 41
cancer (38) 38
graft vs host disease - etiology (37) 37
risk factors (37) 37
survival rate (37) 37
transplants & implants (36) 36
aml (34) 34
blood (34) 34
hematopoietic stem cell transplantation - adverse effects (34) 34
hematology, oncology and palliative medicine (33) 33
1st complete remission (32) 32
child (32) 32
follow-up studies (32) 32
hematologic malignancies (32) 32
chemotherapy (31) 31
immunology (30) 30
patients (30) 30
graft-versus-host reaction (29) 29
transplantation conditioning (29) 29
abridged index medicus (28) 28
health aspects (28) 28
precursor cell lymphoblastic leukemia-lymphoma - therapy (27) 27
acute myelogenous leukemia (26) 26
child, preschool (26) 26
europe (26) 26
hemic and lymphatic diseases (26) 26
incidence (26) 26
hemopoiesis (24) 24
myelodysplastic syndrome (24) 24
reduced-intensity (24) 24
relapse (24) 24
bone marrow transplantation (23) 23
bone-marrow (23) 23
cyclophosphamide (23) 23
graft vs host disease - mortality (23) 23
registries (23) 23
working party (23) 23
[sdv]life sciences [q-bio] (22) 22
acute disease (22) 22
acute lymphoblastic-leukemia (22) 22
transplantation, autologous (22) 22
busulfan (21) 21
graft vs host disease - prevention & control (21) 21
human health and pathology (21) 21
infant (21) 21
outcomes (21) 21
precursor cell lymphoblastic leukemia-lymphoma - mortality (21) 21
therapy (21) 21
acute leukemia (19) 19
allogeneic stem cell transplantation (19) 19
care and treatment (19) 19
children (19) 19
usage (19) 19
adult patients (18) 18
donors (18) 18
fludarabine (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 3556 - 3556
Abstract Abstract 3556 The prognosis of patients with AML harbouring the FlT3 ITD is known to be poor in patients treated with chemotherapy only. However it... 
Journal Article
Blood, ISSN 0006-4971, 10/2016, Volume 128, Issue 15, pp. 1979 - 1986
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2004, Volume 351, Issue 22, pp. 2276 - 2285
Journal Article
Haematologica, ISSN 0390-6078, 02/2010, Volume 95, Issue 2, pp. 284 - 292
Journal Article
JAMA, ISSN 0098-7484, 12/2015, Volume 314, Issue 23, pp. 2524 - 2534
Journal Article
Cancer, ISSN 0008-543X, 04/2018, Volume 124, Issue 7, pp. 1428 - 1437
BACKGROUND Incidence of graft‐versus‐host disease (GVHD) in haploidentical bone marrow (BM) transplants using posttransplantion cyclophosphamide (PT‐Cy) is... 
stem cell source | acute graft‐versus‐host disease | haploidentical transplantation | posttransplantation cyclophosphamide | acute leukemia | acute graft-versus-host disease | SURVIVAL | ALTERNATIVE DONORS | INTENSITY | UNRELATED DONOR TRANSPLANTATION | ACUTE MYELOID-LEUKEMIA | VERSUS-HOST-DISEASE | ONCOLOGY | LEUKEMIA WORKING PARTY | OUTCOMES | HEMATOLOGIC MALIGNANCIES | REMISSION | Myeloablative Agonists - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Male | Leukemia, Myeloid, Acute - immunology | Cyclophosphamide - therapeutic use | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Graft vs Host Disease - mortality | Adult | Female | Retrospective Studies | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Myeloid, Acute - therapy | Leukemia, Myeloid, Acute - pathology | Peripheral Blood Stem Cell Transplantation - mortality | Survival Rate | Combined Modality Therapy | Bone Marrow Transplantation - mortality | Adolescent | Graft vs Host Disease - prevention & control | Aged | Transplantation Conditioning | Transplantation, Haploidentical | Graft-versus-host reaction | Acute lymphatic leukemia | Transplants & implants | Myeloid leukemia | Leukemia | Bone marrow transplantation | Transplants | Transplantation | Lymphatic leukemia | Multivariate analysis | Patients | Survival | Blood | Hematopoietic stem cells | Incidence | Cyclophosphamide | Stem cells | Peripheral blood | Bone marrow | Remission | Acute myeloid leukemia | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 28, pp. 3549 - 3549
Journal Article
Journal Article
16.